Fierce Pharma

The company inked another settlement with a prospective generic maker, [...]

Medical device distribution giant Medline has been slammed for a [...]

In response to a planned healthcare reform initiative in Germany [...]

As its ultra-rare disease med Miplyffa strengthens its foothold in [...]

Cencora and Gilead have expanded their longstanding partnership, cutting a [...]

After a prior misfire in demonstrating its protease inhibitor ensitrelvir’s [...]

HER2 combination strategies are evolving. Hear how biology and next-generation [...]

Although the first-in-class PD-1xVEGF bispecific didn’t disappoint on its overall [...]

In its 2,000-patient Proteus study, J&J tested Erleada’s benefits when [...]

After winning a broader FDA label in metastatic castration-resistant prostate [...]